tlry-10q_20211130.htm
false
2022
Q2
0001731348
--05-31
P10Y
P25Y
P5Y
P5Y
P5Y
P5Y
0
2022
0
0.4
6.7
0
60
0.15
4.29
2.5
3.80
tlry:OperatingLeaseLiabilityMember
tlry:FinanceLeaseLiabilityMember
0.70
0.70
0.05
0.20
http://www.tilray.com/#ValuationTechniqueBlackScholesMember
http://www.tilray.com/#ValuationTechniqueBlackScholesMember
http://fasb.org/us-gaap/2021-01-31#ValuationTechniqueDiscountedCashFlowMember
http://www.tilray.com/#ValuationTechniqueBlackScholesMember
2.5
3.8
1.00
0.00
0.60
0001731348
2021-06-01
2021-11-30
xbrli:shares
0001731348
2022-01-04
iso4217:USD
0001731348
2021-11-30
0001731348
2021-05-31
iso4217:USD
xbrli:shares
0001731348
2021-09-01
2021-11-30
0001731348
2020-09-01
2020-11-30
0001731348
2020-06-01
2020-11-30
0001731348
us-gaap:CommonStockMember
2020-05-31
0001731348
us-gaap:AdditionalPaidInCapitalMember
2020-05-31
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-05-31
0001731348
us-gaap:RetainedEarningsMember
2020-05-31
0001731348
us-gaap:NoncontrollingInterestMember
2020-05-31
0001731348
2020-05-31
0001731348
us-gaap:CommonStockMember
2020-06-01
2020-08-31
0001731348
us-gaap:AdditionalPaidInCapitalMember
2020-06-01
2020-08-31
0001731348
2020-06-01
2020-08-31
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-06-01
2020-08-31
0001731348
us-gaap:RetainedEarningsMember
2020-06-01
2020-08-31
0001731348
us-gaap:NoncontrollingInterestMember
2020-06-01
2020-08-31
0001731348
us-gaap:CommonStockMember
2020-08-31
0001731348
us-gaap:AdditionalPaidInCapitalMember
2020-08-31
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-08-31
0001731348
us-gaap:RetainedEarningsMember
2020-08-31
0001731348
us-gaap:NoncontrollingInterestMember
2020-08-31
0001731348
2020-08-31
0001731348
us-gaap:CommonStockMember
2020-09-01
2020-11-30
0001731348
us-gaap:AdditionalPaidInCapitalMember
2020-09-01
2020-11-30
0001731348
us-gaap:CommonStockMember
tlry:SweetWaterMember
2020-09-01
2020-11-30
0001731348
us-gaap:AdditionalPaidInCapitalMember
tlry:SweetWaterMember
2020-09-01
2020-11-30
0001731348
tlry:SweetWaterMember
2020-09-01
2020-11-30
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-09-01
2020-11-30
0001731348
us-gaap:RetainedEarningsMember
2020-09-01
2020-11-30
0001731348
us-gaap:NoncontrollingInterestMember
2020-09-01
2020-11-30
0001731348
us-gaap:CommonStockMember
2020-11-30
0001731348
us-gaap:AdditionalPaidInCapitalMember
2020-11-30
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-11-30
0001731348
us-gaap:RetainedEarningsMember
2020-11-30
0001731348
us-gaap:NoncontrollingInterestMember
2020-11-30
0001731348
2020-11-30
0001731348
us-gaap:CommonStockMember
2021-05-31
0001731348
us-gaap:AdditionalPaidInCapitalMember
2021-05-31
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-05-31
0001731348
us-gaap:RetainedEarningsMember
2021-05-31
0001731348
us-gaap:NoncontrollingInterestMember
2021-05-31
0001731348
us-gaap:NoncontrollingInterestMember
tlry:SuperheroLPMember
2021-06-01
2021-08-31
0001731348
tlry:SuperheroLPMember
2021-06-01
2021-08-31
0001731348
us-gaap:CommonStockMember
2021-06-01
2021-08-31
0001731348
us-gaap:AdditionalPaidInCapitalMember
2021-06-01
2021-08-31
0001731348
2021-06-01
2021-08-31
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-01
2021-08-31
0001731348
us-gaap:RetainedEarningsMember
2021-06-01
2021-08-31
0001731348
us-gaap:NoncontrollingInterestMember
2021-06-01
2021-08-31
0001731348
us-gaap:CommonStockMember
2021-08-31
0001731348
us-gaap:AdditionalPaidInCapitalMember
2021-08-31
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-08-31
0001731348
us-gaap:RetainedEarningsMember
2021-08-31
0001731348
us-gaap:NoncontrollingInterestMember
2021-08-31
0001731348
2021-08-31
0001731348
us-gaap:CommonStockMember
tlry:SuperheroLPMember
2021-09-01
2021-11-30
0001731348
us-gaap:AdditionalPaidInCapitalMember
tlry:SuperheroLPMember
2021-09-01
2021-11-30
0001731348
tlry:SuperheroLPMember
2021-09-01
2021-11-30
0001731348
us-gaap:CommonStockMember
2021-09-01
2021-11-30
0001731348
us-gaap:AdditionalPaidInCapitalMember
2021-09-01
2021-11-30
0001731348
us-gaap:NoncontrollingInterestMember
2021-09-01
2021-11-30
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-09-01
2021-11-30
0001731348
us-gaap:RetainedEarningsMember
2021-09-01
2021-11-30
0001731348
us-gaap:CommonStockMember
2021-11-30
0001731348
us-gaap:AdditionalPaidInCapitalMember
2021-11-30
0001731348
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-11-30
0001731348
us-gaap:RetainedEarningsMember
2021-11-30
0001731348
us-gaap:NoncontrollingInterestMember
2021-11-30
0001731348
tlry:AphriaIncMember
2021-06-01
2021-11-30
0001731348
us-gaap:AvailableforsaleSecuritiesMember
2021-06-01
2021-11-30
0001731348
tlry:ConvertibleDebenturesMember
2021-06-01
2021-11-30
0001731348
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
2021-06-01
2021-11-30
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
2021-06-01
2021-11-30
0001731348
tlry:MedMenNotesMember
us-gaap:ConvertibleDebtMember
tlry:SuperheroLPMember
2021-08-13
0001731348
tlry:MedMenNotesMember
us-gaap:ConvertibleDebtMember
tlry:SuperheroLPMember
2021-08-13
2021-08-13
0001731348
tlry:SuperheroLPMember
2021-09-17
2021-09-17
xbrli:pure
0001731348
tlry:SuperheroLPMember
2021-08-13
0001731348
tlry:MedMenNotesAndWarrantsMember
2021-08-13
0001731348
tlry:SuperheroLPMember
2021-08-13
2021-08-13
0001731348
tlry:MedMenNotesAndWarrantsMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2021-06-01
2021-11-30
0001731348
tlry:MedMenNotesAndWarrantsMember
us-gaap:LondonInterbankOfferedRateLIBORMember
us-gaap:InterestRateFloorMember
2021-06-01
2021-11-30
0001731348
tlry:PlantsMember
2021-11-30
0001731348
tlry:PlantsMember
2021-05-31
0001731348
tlry:DriedCannabisMember
2021-11-30
0001731348
tlry:DriedCannabisMember
2021-05-31
0001731348
tlry:CannabisTrimMember
2021-11-30
0001731348
tlry:CannabisTrimMember
2021-05-31
0001731348
tlry:CannabisDerivativesMember
2021-11-30
0001731348
tlry:CannabisDerivativesMember
2021-05-31
0001731348
tlry:CannabisVapesMember
2021-11-30
0001731348
tlry:CannabisVapesMember
2021-05-31
0001731348
tlry:PackagingAndOtherInventoryItemsMember
2021-11-30
0001731348
tlry:PackagingAndOtherInventoryItemsMember
2021-05-31
0001731348
tlry:WellnessInventoryMember
2021-11-30
0001731348
tlry:WellnessInventoryMember
2021-05-31
0001731348
tlry:BeverageAlcoholInventoryMember
2021-11-30
0001731348
tlry:BeverageAlcoholInventoryMember
2021-05-31
0001731348
tlry:DistributionInventoryMember
2021-11-30
0001731348
tlry:DistributionInventoryMember
2021-05-31
0001731348
tlry:CannabisMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisMember
2020-06-01
2020-11-30
0001731348
us-gaap:LandMember
2021-11-30
0001731348
us-gaap:LandMember
2021-05-31
0001731348
us-gaap:ManufacturingFacilityMember
2021-11-30
0001731348
us-gaap:ManufacturingFacilityMember
2021-05-31
0001731348
us-gaap:EquipmentMember
2021-11-30
0001731348
us-gaap:EquipmentMember
2021-05-31
0001731348
us-gaap:LeaseholdImprovementsMember
2021-11-30
0001731348
us-gaap:LeaseholdImprovementsMember
2021-05-31
0001731348
tlry:ROUAssetsUnderFinanceLeaseMember
2021-11-30
0001731348
tlry:ROUAssetsUnderFinanceLeaseMember
2021-05-31
0001731348
us-gaap:ConstructionInProgressMember
2021-11-30
0001731348
us-gaap:ConstructionInProgressMember
2021-05-31
0001731348
tlry:CustomerRelationshipsAndDistributionChannelMember
2021-05-31
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-05-31
0001731348
us-gaap:NoncompeteAgreementsMember
2021-05-31
0001731348
tlry:IntellectualPropertyTrademarksKnowHowAndBrandsMember
2021-05-31
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-06-01
2021-08-31
0001731348
tlry:IntellectualPropertyTrademarksKnowHowAndBrandsMember
2021-06-01
2021-08-31
0001731348
tlry:CustomerRelationshipsAndDistributionChannelMember
2021-06-01
2021-08-31
0001731348
us-gaap:NoncompeteAgreementsMember
2021-06-01
2021-08-31
0001731348
tlry:CustomerRelationshipsAndDistributionChannelMember
2021-08-31
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-08-31
0001731348
us-gaap:NoncompeteAgreementsMember
2021-08-31
0001731348
tlry:IntellectualPropertyTrademarksKnowHowAndBrandsMember
2021-08-31
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-09-01
2021-11-30
0001731348
tlry:IntellectualPropertyTrademarksKnowHowAndBrandsMember
2021-09-01
2021-11-30
0001731348
tlry:CustomerRelationshipsAndDistributionChannelMember
2021-09-01
2021-11-30
0001731348
tlry:CustomerRelationshipsAndDistributionChannelMember
2021-11-30
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-11-30
0001731348
us-gaap:NoncompeteAgreementsMember
2021-11-30
0001731348
tlry:IntellectualPropertyTrademarksKnowHowAndBrandsMember
2021-11-30
0001731348
us-gaap:NoncompeteAgreementsMember
2021-09-01
2021-11-30
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-11-30
0001731348
tlry:LicencesPermitsAndApplicationsMember
2021-05-31
0001731348
tlry:BrokenCoastCannabisLtdMember
tlry:CannabisBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:BrokenCoastCannabisLtdMember
tlry:CannabisBusinessMember
2020-06-01
2021-05-31
0001731348
tlry:NuuveraCorpMember
tlry:CannabisBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:NuuveraCorpMember
tlry:CannabisBusinessMember
2020-06-01
2021-05-31
0001731348
tlry:LATAMHoldingsIncMember
tlry:CannabisBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:LATAMHoldingsIncMember
tlry:CannabisBusinessMember
2020-06-01
2021-05-31
0001731348
tlry:CCPharmaGmbHMember
tlry:DistributionBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaGmbHMember
tlry:DistributionBusinessMember
2020-06-01
2021-05-31
0001731348
tlry:SweetWaterMember
tlry:BeverageAlcoholBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:SweetWaterMember
tlry:BeverageAlcoholBusinessMember
2020-06-01
2021-05-31
0001731348
tlry:TilrayMember
tlry:CannabisBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:TilrayMember
tlry:CannabisBusinessMember
2020-06-01
2021-05-31
0001731348
tlry:TilrayMember
tlry:HempBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:TilrayMember
tlry:HempBusinessMember
2020-06-01
2021-05-31
0001731348
2020-06-01
2021-05-31
0001731348
tlry:AphriaIncMember
2021-11-30
0001731348
tlry:AphriaIncMember
2021-05-31
0001731348
us-gaap:DistributionRightsMember
tlry:AphriaIncMember
2021-11-30
0001731348
us-gaap:DistributionRightsMember
tlry:AphriaIncMember
2021-05-31
0001731348
us-gaap:CustomerRelationshipsMember
tlry:AphriaIncMember
2021-11-30
0001731348
us-gaap:CustomerRelationshipsMember
tlry:AphriaIncMember
2021-05-31
0001731348
tlry:KnowHowMember
tlry:AphriaIncMember
2021-11-30
0001731348
tlry:KnowHowMember
tlry:AphriaIncMember
2021-05-31
0001731348
tlry:BrandsMember
tlry:AphriaIncMember
2021-11-30
0001731348
tlry:BrandsMember
tlry:AphriaIncMember
2021-05-31
0001731348
us-gaap:LicensingAgreementsMember
tlry:AphriaIncMember
2021-11-30
0001731348
us-gaap:LicensingAgreementsMember
tlry:AphriaIncMember
2021-05-31
0001731348
us-gaap:DistributionRightsMember
tlry:AphriaIncMember
2021-06-01
2021-11-30
0001731348
us-gaap:DistributionRightsMember
tlry:AphriaIncMember
2020-06-01
2021-05-31
0001731348
us-gaap:CustomerRelationshipsMember
tlry:AphriaIncMember
2021-06-01
2021-11-30
0001731348
us-gaap:CustomerRelationshipsMember
tlry:AphriaIncMember
2020-06-01
2021-05-31
0001731348
tlry:KnowHowMember
tlry:AphriaIncMember
2021-06-01
2021-11-30
0001731348
tlry:KnowHowMember
tlry:AphriaIncMember
2020-06-01
2021-05-31
0001731348
srt:MinimumMember
tlry:BrandsMember
tlry:AphriaIncMember
2021-06-01
2021-11-30
0001731348
tlry:BrandsMember
tlry:AphriaIncMember
srt:MaximumMember
2021-06-01
2021-11-30
0001731348
srt:MinimumMember
tlry:BrandsMember
tlry:AphriaIncMember
2020-06-01
2021-05-31
0001731348
srt:MaximumMember
tlry:BrandsMember
tlry:AphriaIncMember
2020-06-01
2021-05-31
0001731348
us-gaap:FairValueInputsLevel1Member
2021-11-30
0001731348
us-gaap:FairValueInputsLevel1Member
2021-05-31
0001731348
us-gaap:FairValueInputsLevel2Member
2021-11-30
0001731348
us-gaap:FairValueInputsLevel2Member
2021-05-31
0001731348
tlry:MedMenNotesMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2021-06-01
2021-11-30
0001731348
tlry:MedMenNotesMember
us-gaap:LondonInterbankOfferedRateLIBORMember
us-gaap:InterestRateFloorMember
2021-06-01
2021-11-30
0001731348
tlry:MedMenNotesMember
2021-06-01
2021-11-30
0001731348
us-gaap:EquitySecuritiesMember
us-gaap:OtherLongTermInvestmentsMember
2021-11-30
0001731348
us-gaap:EquitySecuritiesMember
2021-11-30
0001731348
us-gaap:EquitySecuritiesMember
2021-09-01
2021-11-30
0001731348
us-gaap:EquitySecuritiesMember
2021-06-01
2021-11-30
utr:Y
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedTermMember
srt:MinimumMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedTermMember
srt:MaximumMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputPriceVolatilityMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputRiskFreeInterestRateMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedDividendRateMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputProbabilityOfConversionMember
srt:MinimumMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputProbabilityOfConversionMember
srt:MaximumMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputStrikePriceMember
srt:MinimumMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputStrikePriceMember
srt:MaximumMember
2021-11-30
0001731348
us-gaap:DebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputFairValueOfCommonStockMember
2021-11-30
iso4217:CAD
0001731348
us-gaap:PrimeRateMember
2021-06-01
2021-11-30
iso4217:EUR
0001731348
tlry:CCPharmaMember
tlry:OperatingLinesOfCreditOneMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaMember
tlry:OperatingLinesOfCreditTwoMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaMember
tlry:OperatingLinesOfCreditThreeMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaMember
2021-11-30
tlry:Lineofcredit
0001731348
tlry:CCPharmaMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaMember
tlry:OperatingLinesOfCreditOneMember
tlry:EuroOverNightIndexAveragePlusMember
2021-11-30
0001731348
tlry:CCPharmaMember
tlry:OperatingLinesOfCreditTwoMember
tlry:EuroInterbankOfferedRatePlusMember
2021-11-30
0001731348
tlry:EUROBIRRateMember
tlry:FourTwentyCorporationMember
us-gaap:RevolvingCreditFacilityMember
2021-11-30
0001731348
tlry:FourTwentyCorporationMember
us-gaap:RevolvingCreditFacilityMember
2021-11-30
0001731348
tlry:CreditFacilityDueInNovemberTwoThousandTwentyTwoMember
2021-11-30
0001731348
tlry:CreditFacilityDueInNovemberTwoThousandTwentyTwoMember
2021-05-31
0001731348
tlry:TermLoanDueInJulyTwoThousandTwentyThreeMember
2021-11-30
0001731348
tlry:TermLoanDueInJulyTwoThousandTwentyThreeMember
2021-05-31
0001731348
tlry:TermLoanDueInAprilTwoThousandTwentyTwoMember
2021-11-30
0001731348
tlry:TermLoanDueInAprilTwoThousandTwentyTwoMember
2021-05-31
0001731348
tlry:TermLoanDueInAugustTwoThousandTwentySixMember
2021-11-30
0001731348
tlry:TermLoanDueInAugustTwoThousandTwentySixMember
2021-05-31
0001731348
tlry:MortgagePayableDueInAugustTwoThousandTwentySixMember
2021-11-30
0001731348
tlry:MortgagePayableDueInAugustTwoThousandTwentySixMember
2021-05-31
0001731348
tlry:VendorTakeBackMortgageDueInJuneTwoThousandTwentyOneMember
2021-05-31
0001731348
tlry:TermLoanDueInDecemberTwoThousandTwentyThreeMember
tlry:EuroInterbankOfferedRatePlusOnePointSevenNinePercentageMember
2021-11-30
0001731348
tlry:TermLoanDueInDecemberTwoThousandTwentyThreeMember
tlry:EuroInterbankOfferedRatePlusOnePointSevenNinePercentageMember
2021-05-31
0001731348
tlry:TermLoanDueInDecemberTwoThousandTwentyThreeMember
tlry:EuroInterbankOfferedRatePlusTwoPointSixEightPercentageMember
2021-11-30
0001731348
tlry:TermLoanDueInDecemberTwoThousandTwentyThreeMember
tlry:EuroInterbankOfferedRatePlusTwoPointSixEightPercentageMember
2021-05-31
0001731348
tlry:TermLoanDueInAprilTwoThousandTwentyFiveMember
tlry:EuroInterbankOfferedRatePlusTwoPointZeroZeroPercentageMember
2021-11-30
0001731348
tlry:TermLoanDueInAprilTwoThousandTwentyFiveMember
tlry:EuroInterbankOfferedRatePlusTwoPointZeroZeroPercentageMember
2021-05-31
0001731348
tlry:TermLoanDueInJuneTwoThousandTwentyFiveMember
tlry:EuroInterbankOfferedRatePlusTwoPointZeroZeroPercentageMember
2021-11-30
0001731348
tlry:TermLoanDueInJuneTwoThousandTwentyFiveMember
tlry:EuroInterbankOfferedRatePlusTwoPointZeroZeroPercentageMember
2021-05-31
0001731348
tlry:TermLoanDueInMarchTwoThousandTwentyFourMember
tlry:EUROBIRRateMember
2021-11-30
0001731348
tlry:TermLoanDueInMarchTwoThousandTwentyFourMember
tlry:EUROBIRRateMember
2021-05-31
0001731348
tlry:CreditFacilityDueInNovemberTwoThousandTwentyTwoMember
tlry:CanadianPrimeInterestRateMember
2021-11-30
0001731348
tlry:CreditFacilityDueInNovemberTwoThousandTwentyTwoMember
tlry:CanadianPrimeInterestRateMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInJulyTwoThousandTwentyThreeMember
tlry:CanadianFiveYearBondInterestRatePlusTwoPointSevenThreeMember
2021-11-30
0001731348
tlry:TermLoanDueInJulyTwoThousandTwentyThreeMember
tlry:CanadianFiveYearBondInterestRatePlusTwoPointSevenThreeMember
srt:MinimumMember
2021-11-30
0001731348
tlry:TermLoanDueInJulyTwoThousandTwentyThreeMember
tlry:CanadianFiveYearBondInterestRatePlusTwoPointSevenThreeMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInAprilTwoThousandTwentyTwoMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInAugustTwoThousandTwentySixMember
2021-06-01
2021-11-30
0001731348
tlry:MortgagePayableDueInAugustTwoThousandTwentySixMember
2021-06-01
2021-11-30
0001731348
tlry:VendorTakeBackMortgageDueInJuneTwoThousandTwentyOneMember
2021-11-30
0001731348
tlry:VendorTakeBackMortgageDueInJuneTwoThousandTwentyOneMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInDecemberTwoThousandTwentyThreeMember
tlry:EuroInterbankOfferedRatePlusOnePointSevenNinePercentageMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInDecemberTwoThousandTwentyThreeMember
tlry:EuroInterbankOfferedRatePlusTwoPointSixEightPercentageMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInAprilTwoThousandTwentyFiveMember
tlry:EuroInterbankOfferedRatePlusTwoPointZeroZeroPercentageMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInJuneTwoThousandTwentyFiveMember
tlry:EuroInterbankOfferedRatePlusTwoPointZeroZeroPercentageMember
2021-06-01
2021-11-30
0001731348
tlry:TermLoanDueInMarchTwoThousandTwentyFourMember
tlry:EUROBIRRateMember
2021-06-01
2021-11-30
0001731348
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
2021-11-30
0001731348
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
2021-05-31
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
2021-11-30
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
2021-05-31
0001731348
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
tlry:FivePointTwoFivePercentageContractualDebentureMember
2021-05-31
0001731348
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
tlry:FivePointTwoFivePercentageContractualDebentureMember
2020-05-31
0001731348
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
2020-06-01
2021-05-31
0001731348
tlry:TilrayMember
us-gaap:CommonStockMember
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
2021-06-01
2021-11-30
0001731348
tlry:TilrayMember
us-gaap:CommonStockMember
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
2021-11-30
tlry:Tradingday
0001731348
us-gaap:MeasurementInputRiskFreeInterestRateMember
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
us-gaap:FairValueInputsLevel3Member
2021-11-30
0001731348
us-gaap:MeasurementInputPriceVolatilityMember
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
us-gaap:FairValueInputsLevel3Member
2021-11-30
0001731348
us-gaap:MeasurementInputExpectedTermMember
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
us-gaap:FairValueInputsLevel3Member
2021-11-30
0001731348
us-gaap:MeasurementInputExpectedDividendRateMember
tlry:FivePointTwoFivePercentageConvertibleNotesAPHA24Member
us-gaap:FairValueInputsLevel3Member
2021-11-30
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
tlry:FivePointTwoFivePercentageContractualDebentureMember
2021-05-31
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
tlry:FivePointTwoFivePercentageContractualDebentureMember
2020-05-31
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
2020-06-01
2021-05-31
0001731348
tlry:FivePointZeroZeroPercentageConvertibleNotesTLRY23Member
2020-05-31
0001731348
tlry:WarrantExpiringSeptemberTwentySixTwoThousandTwentyOneMember
2021-06-01
2021-11-30
0001731348
tlry:WarrantExpiringJanuaryThirtyTwoThousandTwentyTwoMember
2021-06-01
2021-11-30
0001731348
tlry:WarrantExpiringMarchSeventeenTwoThousandTwentyFiveMember
2021-06-01
2021-11-30
0001731348
tlry:WarrantExpiringSeptemberTwentySixTwoThousandTwentyOneMember
2021-11-30
0001731348
tlry:WarrantExpiringJanuaryThirtyTwoThousandTwentyTwoMember
2021-11-30
0001731348
tlry:WarrantExpiringMarchSeventeenTwoThousandTwentyFiveMember
2021-11-30
0001731348
tlry:WarrantExpiringSeptemberTwentySixTwoThousandTwentyOneMember
2021-05-31
0001731348
tlry:WarrantExpiringJanuaryThirtyTwoThousandTwentyTwoMember
2021-05-31
0001731348
tlry:WarrantExpiringMarchSeventeenTwoThousandTwentyFiveMember
2021-05-31
0001731348
us-gaap:FairValueInputsLevel3Member
2021-11-30
0001731348
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputRiskFreeInterestRateMember
2021-11-30
0001731348
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputPriceVolatilityMember
2021-11-30
0001731348
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedTermMember
2021-11-30
0001731348
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputExpectedDividendRateMember
2021-11-30
0001731348
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputStrikePriceMember
2021-11-30
0001731348
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
tlry:MeasurementInputFairValueOfCommonStockMember
2021-11-30
0001731348
tlry:PredecessorPlanMember
2021-09-01
2021-11-30
0001731348
tlry:PredecessorPlanMember
2021-06-01
2021-11-30
0001731348
tlry:StockOptionsMember
2021-09-01
2021-11-30
0001731348
tlry:StockOptionsMember
2020-09-01
2020-11-30
0001731348
tlry:StockOptionsMember
2021-06-01
2021-11-30
0001731348
tlry:StockOptionsMember
2020-06-01
2020-11-30
0001731348
us-gaap:RestrictedStockUnitsRSUMember
2021-09-01
2021-11-30
0001731348
us-gaap:RestrictedStockUnitsRSUMember
2020-09-01
2020-11-30
0001731348
us-gaap:RestrictedStockUnitsRSUMember
2021-06-01
2021-11-30
0001731348
us-gaap:RestrictedStockUnitsRSUMember
2020-06-01
2020-11-30
0001731348
us-gaap:AccumulatedTranslationAdjustmentMember
2021-05-31
0001731348
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2021-05-31
0001731348
us-gaap:AccumulatedTranslationAdjustmentMember
2021-06-01
2021-08-31
0001731348
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2021-06-01
2021-08-31
0001731348
us-gaap:AccumulatedTranslationAdjustmentMember
2021-08-31
0001731348
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2021-08-31
0001731348
us-gaap:AccumulatedTranslationAdjustmentMember
2021-09-01
2021-11-30
0001731348
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2021-09-01
2021-11-30
0001731348
tlry:UnrealizedLossOnAvailableForSaleDebtSecuritiesMember
2021-09-01
2021-11-30
0001731348
us-gaap:AccumulatedTranslationAdjustmentMember
2021-11-30
0001731348
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2021-11-30
0001731348
tlry:UnrealizedLossOnAvailableForSaleDebtSecuritiesMember
2021-11-30
0001731348
tlry:SuperheroLPMember
2021-09-01
2021-11-30
0001731348
tlry:SuperheroLPMember
2021-06-01
2021-11-30
0001731348
tlry:AphriaDiamondMember
2021-09-01
2021-11-30
0001731348
tlry:AphriaDiamondMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaNordicApSMember
us-gaap:NoncontrollingInterestMember
2021-11-30
0001731348
tlry:AphriaDiamondMember
us-gaap:NoncontrollingInterestMember
2021-11-30
0001731348
tlry:ColCannaSASMember
us-gaap:NoncontrollingInterestMember
2021-11-30
0001731348
tlry:SuperheroLPMember
us-gaap:NoncontrollingInterestMember
2021-11-30
0001731348
tlry:CCPharmaNordicApSMember
us-gaap:NoncontrollingInterestMember
2021-05-31
0001731348
tlry:AphriaDiamondMember
us-gaap:NoncontrollingInterestMember
2021-05-31
0001731348
tlry:ColCannaSASMember
us-gaap:NoncontrollingInterestMember
2021-05-31
0001731348
tlry:CCPharmaNordicApSMember
us-gaap:NoncontrollingInterestMember
2021-06-01
2021-11-30
0001731348
tlry:AphriaDiamondMember
us-gaap:NoncontrollingInterestMember
2021-06-01
2021-11-30
0001731348
us-gaap:NoncontrollingInterestMember
2021-06-01
2021-11-30
0001731348
tlry:ColCannaSASMember
us-gaap:NoncontrollingInterestMember
2021-06-01
2021-11-30
0001731348
tlry:SuperheroLPMember
us-gaap:NoncontrollingInterestMember
2021-06-01
2021-11-30
0001731348
tlry:CCPharmaNordicApSMember
us-gaap:NoncontrollingInterestMember
2020-06-01
2020-11-30
0001731348
tlry:AphriaDiamondMember
us-gaap:NoncontrollingInterestMember
2020-06-01
2020-11-30
0001731348
us-gaap:NoncontrollingInterestMember
2020-06-01
2020-11-30
0001731348
tlry:ColCannaSASMember
us-gaap:NoncontrollingInterestMember
2020-06-01
2020-11-30
0001731348
tlry:CCPharmaNordicApSMember
us-gaap:NoncontrollingInterestMember
2020-11-30
0001731348
tlry:AphriaDiamondMember
us-gaap:NoncontrollingInterestMember
2020-11-30
0001731348
tlry:ColCannaSASMember
us-gaap:NoncontrollingInterestMember
2020-11-30
0001731348
tlry:LongTermDebtRepaymentMember
2021-11-30
0001731348
tlry:ConvertibleNotesPrincipalAndInterestMember
2021-11-30
0001731348
tlry:MaterialPurchaseObligationsMember
2021-11-30
0001731348
tlry:ConstructionCommitmentMember
2021-11-30
0001731348
tlry:ABGIntermediateHoldings2LLCMember
2021-11-10
0001731348
tlry:ABGIntermediateHoldings2LLCMember
2021-11-10
2021-11-10
0001731348
tlry:ABGIntermediateHoldings2LLCMember
tlry:ClassTwoCommonSharesMember
2021-11-10
2021-11-10
tlry:Segment
0001731348
tlry:CannabisRevenueMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisRevenueMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisRevenueMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisRevenueMember
2020-06-01
2020-11-30
0001731348
tlry:CannabisExciseTaxesMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisExciseTaxesMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisExciseTaxesMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisExciseTaxesMember
2020-06-01
2020-11-30
0001731348
tlry:CannabisRevenueNetMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisRevenueNetMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisRevenueNetMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisRevenueNetMember
2020-06-01
2020-11-30
0001731348
tlry:BeverageAlcoholRevenueMember
2021-09-01
2021-11-30
0001731348
tlry:BeverageAlcoholRevenueMember
2020-09-01
2020-11-30
0001731348
tlry:BeverageAlcoholRevenueMember
2021-06-01
2021-11-30
0001731348
tlry:BeverageAlcoholRevenueMember
2020-06-01
2020-11-30
0001731348
tlry:BeverageAlcoholExciseTaxesMember
2021-09-01
2021-11-30
0001731348
tlry:BeverageAlcoholExciseTaxesMember
2020-09-01
2020-11-30
0001731348
tlry:BeverageAlcoholExciseTaxesMember
2021-06-01
2021-11-30
0001731348
tlry:BeverageAlcoholExciseTaxesMember
2020-06-01
2020-11-30
0001731348
tlry:BeverageAlcoholRevenueNetMember
2021-09-01
2021-11-30
0001731348
tlry:BeverageAlcoholRevenueNetMember
2020-09-01
2020-11-30
0001731348
tlry:BeverageAlcoholRevenueNetMember
2021-06-01
2021-11-30
0001731348
tlry:BeverageAlcoholRevenueNetMember
2020-06-01
2020-11-30
0001731348
tlry:DistributionRevenueMember
2021-09-01
2021-11-30
0001731348
tlry:DistributionRevenueMember
2020-09-01
2020-11-30
0001731348
tlry:DistributionRevenueMember
2021-06-01
2021-11-30
0001731348
tlry:DistributionRevenueMember
2020-06-01
2020-11-30
0001731348
tlry:WellnessRevenueMember
2021-09-01
2021-11-30
0001731348
tlry:WellnessRevenueMember
2021-06-01
2021-11-30
0001731348
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
us-gaap:FairValueInputsLevel3Member
tlry:APHATwentyFourConvertibleDebentureMember
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
tlry:APHATwentyFourConvertibleDebentureMember
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
us-gaap:FairValueInputsLevel3Member
tlry:APHATwentyFourConvertibleDebentureMember
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
tlry:APHATwentyFourConvertibleDebentureMember
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
us-gaap:MeasurementInputDiscountRateMember
2021-11-30
0001731348
tlry:WarrantLiabilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
tlry:ContingentConsiderationsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-05-31
0001731348
tlry:DebtSecuritiesAvailableForSaleMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-06-01
2021-11-30
0001731348
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-06-01
2021-11-30
0001731348
tlry:APHATwentyFourConvertibleDebentureMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-06-01
2021-11-30
0001731348
tlry:WarrantLiabilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-06-01
2021-11-30
0001731348
tlry:ContingentConsiderationsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-06-01
2021-11-30
0001731348
tlry:WarrantLiabilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
tlry:ContingentConsiderationsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
tlry:DebtSecuritiesAvailableForSaleMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2021-11-30
0001731348
us-gaap:MeasurementInputOptionVolatilityMember
2021-11-30
0001731348
us-gaap:MeasurementInputExpectedTermMember
2021-11-30
0001731348
tlry:MeasurementInputAchievementRateMember
2021-11-30
0001731348
tlry:MeasurementInputInterestRateMember
2021-11-30
0001731348
us-gaap:MeasurementInputConversionPriceMember
srt:MinimumMember
2021-11-30
0001731348
us-gaap:MeasurementInputConversionPriceMember
srt:MaximumMember
2021-11-30
0001731348
tlry:CannabisBusinessMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisBusinessMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisBusinessMember
2020-06-01
2020-11-30
0001731348
tlry:DistributionBusinessMember
2021-09-01
2021-11-30
0001731348
tlry:DistributionBusinessMember
2020-09-01
2020-11-30
0001731348
tlry:DistributionBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:DistributionBusinessMember
2020-06-01
2020-11-30
0001731348
tlry:BeverageAlcoholBusinessMember
2021-09-01
2021-11-30
0001731348
tlry:BeverageAlcoholBusinessMember
2020-09-01
2020-11-30
0001731348
tlry:BeverageAlcoholBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:BeverageAlcoholBusinessMember
2020-06-01
2020-11-30
0001731348
tlry:WellnessBusinessMember
2021-09-01
2021-11-30
0001731348
tlry:WellnessBusinessMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:CanadianMedicalProductsMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:CanadianMedicalProductsMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:CanadianMedicalProductsMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:CanadianMedicalProductsMember
2020-06-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:CanadianAdultUseProductsMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:CanadianAdultUseProductsMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:CanadianAdultUseProductsMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:CanadianAdultUseProductsMember
2020-06-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:WholesaleProductsMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:WholesaleProductsMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:WholesaleProductsMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:WholesaleProductsMember
2020-06-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:InternationalProductsMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:InternationalProductsMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisMember
tlry:InternationalProductsMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
tlry:InternationalProductsMember
2020-06-01
2020-11-30
0001731348
tlry:CannabisMember
2021-09-01
2021-11-30
0001731348
tlry:CannabisMember
2020-09-01
2020-11-30
0001731348
tlry:CannabisMember
2021-06-01
2021-11-30
0001731348
tlry:CannabisMember
2020-06-01
2020-11-30
0001731348
srt:NorthAmericaMember
2021-09-01
2021-11-30
0001731348
srt:NorthAmericaMember
2020-09-01
2020-11-30
0001731348
srt:NorthAmericaMember
2021-06-01
2021-11-30
0001731348
srt:NorthAmericaMember
2020-06-01
2020-11-30
0001731348
us-gaap:EMEAMember
2021-09-01
2021-11-30
0001731348
us-gaap:EMEAMember
2020-09-01
2020-11-30
0001731348
us-gaap:EMEAMember
2021-06-01
2021-11-30
0001731348
us-gaap:EMEAMember
2020-06-01
2020-11-30
0001731348
tlry:RestOfWorldMember
2021-09-01
2021-11-30
0001731348
tlry:RestOfWorldMember
2020-09-01
2020-11-30
0001731348
tlry:RestOfWorldMember
2021-06-01
2021-11-30
0001731348
tlry:RestOfWorldMember
2020-06-01
2020-11-30
0001731348
srt:NorthAmericaMember
2021-11-30
0001731348
srt:NorthAmericaMember
2021-05-31
0001731348
us-gaap:EMEAMember
2021-11-30
0001731348
us-gaap:EMEAMember
2021-05-31
0001731348
tlry:RestOfWorldMember
2021-11-30
0001731348
tlry:RestOfWorldMember
2021-05-31
0001731348
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
tlry:MajorCustomersMember
2021-09-01
2021-11-30
0001731348
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
tlry:MajorCustomersMember
2020-09-01
2020-11-30
0001731348
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
tlry:MajorCustomersMember
2021-06-01
2021-11-30
0001731348
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
tlry:MajorCustomersMember
2020-06-01
2020-11-30
tlry:Customer
0001731348
tlry:SWAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-01
2021-12-01
0001731348
tlry:CommonClassTwoMember
tlry:SWAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-01
2021-12-01
0001731348
tlry:CommonClassTwoMember
tlry:SWAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-17
2021-12-17
0001731348
tlry:BreckenridgeAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-07
2021-12-07
0001731348
tlry:CommonClassTwoMember
tlry:BreckenridgeAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-07
2021-12-07
0001731348
tlry:FacilityAmendmentMember
tlry:BankOfMontrealMember
us-gaap:SubsequentEventMember
us-gaap:LongTermDebtMember
2021-12-07
0001731348
tlry:FacilityAmendmentMember
tlry:BankOfMontrealMember
us-gaap:SubsequentEventMember
2021-12-07
0001731348
tlry:AlpineAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-17
2021-12-17
0001731348
tlry:CommonClassTwoMember
tlry:AlpineAcquisitionMember
us-gaap:SubsequentEventMember
2021-12-17
2021-12-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended November 30, 2021
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-38594
TILRAY, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
82-4310622 |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer Identification No.) |
655 Madison Avenue, Suite 1900
New York, NY |
10065 |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (844) 845-7291
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on which registered |
Class 2 Common Stock, $0.0001 par value per share |
|
TLRY |
|
The Nasdaq Global Select Market |
|
|
|
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☒ No ☐
As of January 4, 2022, the registrant had 466,522,611 shares of common stock, $0.0001 par value per share, issued and outstanding.
Table of Contents
i
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 (the “Form 10-Q”) contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,”” might,” “plan,” “project,” “will,” “would” ”seek,” or “should,” or the negative or plural of these words or similar expressions or variations are intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives, business strategy, supply chain, brand portfolio and product performance; the COVID-19 pandemic; current or future macroeconomic trends; and future corporate acquisitions and strategic transactions.
Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: our ability to successfully complete the integration of the businesses of Tilray and Aphria; challenges and uncertainty resulting from the COVID-19 pandemic; the highly regulated environment in which we operate and our dependence on regulatory approvals and licenses; our ability to manage our supply chain effectively; disruption of operations at our cultivation and manufacturing facilities; challenges and uncertainty resulting from the impact of competition; our ability to manage risks associated with our international sales and operations; our ability to successfully develop and commercialize new products; our ability to execute our strategic plan and other initiatives, including our ability to achieve $4 billion of revenue by the end of our fiscal year 2024; our dependency on significant customers, which generate a significant amount of our revenue; input cost inflation; disruptions to information technology systems; pending and future litigation; volatility in our stock; our ability to raise funds; and other risks and matters described in our most recent Annual Report on Form 10-K, this Form 10-Q and our other filings from time to time with the U.S. Securities and Exchange Commission and in our Canadian securities filings.
Forward looking statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q and, while we believe that information provides a reasonable basis for these statements, these statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. You should not rely upon forward-looking statements or forward-looking information as predictions of future events.
We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.
ii
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
TILRAY, INC.
Consolidated Statements of Financial Position
(in thousands of United States dollars, unaudited)
|
|
November 30,
2021 |
|
|
May 31,
2021 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
331,783 |
|
|
$ |
488,466 |
|
Accounts receivable, net |
|
|
84,575 |
|
|
|
87,309 |
|
Inventory |
|
|
233,020 |
|
|
|
256,429 |
|
Prepaids and other current assets |
|
|
57,340 |
|
|
|
48,920 |
|
Convertible notes receivable |
|
|
1,560 |
|
|
|
2,485 |
|
Total current assets |
|
|
708,278 |
|
|
|
883,609 |
|
Capital assets |
|
|
604,249 |
|
|
|
650,698 |
|
Right-of-use assets |
|
|
13,933 |
|
|
|
18,267 |
|
Intangible assets |
|
|
1,450,015 |
|
|
|
1,605,918 |
|
Goodwill |
|
|
2,814,163 |
|
|
|
2,832,794 |
|
Interest in equity investees |
|
|
4,440 |
|
|
|
8,106 |
|
Long-term investments |
|
|
168,244 |
|
|
|
17,685 |
|
Other assets |
|
|
164 |
|
|
|
8,285 |
|
Total assets |
|
$ |
5,763,486 |
|
|
$ |
6,025,362 |
|
Liabilities |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Bank indebtedness |
|
$ |
8,736 |
|
|
$ |
8,717 |
|
Accounts payable and accrued liabilities |
|
|
168,300 |
|
|
|
212,813 |
|
Contingent consideration |
|
|
62,339 |
|
|
|
60,657 |
|
Warrant liability |
|
|
40,455 |
|
|
|
78,168 |
|
Current portion of lease liabilities |
|
|
3,588 |
|
|
|
4,264 |
|
Current portion of long-term debt |
|
|
31,510 |
|
|
|
36,622 |
|
Total current liabilities |
|
|
314,928 |
|
|
|
401,241 |
|
Long - term liabilities |
|
|
|
|
|
|
|
|
Lease liabilities |
|
|
49,265 |
|
|
|
53,946 |
|
Long-term debt |
|
|
151,819 |
|
|
|
167,486 |
|
Convertible debentures |
|
|
554,854 |
|
|
|
667,624 |
|
Deferred tax liability |
|
|
219,311 |
|
|
|
265,845 |
|
Other liabilities |
|
|
320 |
|
|
|
3,907 |
|
Total liabilities |
|
|
1,290,497 |
|
|
|
1,560,049 |
|
Commitments and contingencies (refer to Note 17) |
|
|
|
|
|
|
|
|
Shareholders' equity |
|
|
|
|
|
|
|
|
Common stock ($0.0001 par value; 990,000,000 shares authorized; 463,802,393 and 265,423,304 shares issued and outstanding, respectively) |
|
|
46 |
|
|
|
46 |
|
Additional paid-in capital |
|
|
4,954,547 |
|
|
|
4,792,406 |
|
Accumulated other comprehensive income |
|
|
9,595 |
|
|
|
152,668 |
|
Accumulated Deficit |
|
|
(527,900 |
) |
|
|
(486,050 |
) |
Total Tilray shareholders' equity |
|
|
4,436,288 |
|
|
|
4,459,070 |
|
Non-controlling interests |
|
|
36,701 |
|
|
|
6,243 |
|
Total shareholders' equity |
|
|
4,472,989 |
|
|
|
4,465,313 |
|
Total liabilities and shareholders' equity |
|
$ |
5,763,486 |
|
|
$ |
6,025,362 |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
1
TILRAY, INC.
Consolidated Statements of Income (Loss) and Comprehensive Loss
(in thousands of United States dollars, except for share and per share data, unaudited)
|
|
Three months ended November 30, |
|
|
Six months ended November 30, |
|
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Net revenue |
|
$ |
155,153 |
|
|
$ |
129,459 |
|
|
$ |
323,176 |
|
|
$ |
246,949 |
|
Cost of goods sold |
|
|
122,387 |
|
|
|
94,176 |
|
|
|
239,455 |
|
|
|
176,721 |
|
Gross profit |
|
|
32,766 |
|
|
|
35,283 |
|
|
|
83,721 |
|
|
|
70,228 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative |
|
|
33,469 |
|
|
|
28,273 |
|
|
|
82,956 |
|
|
|
54,245 |
|
Selling |
|
|
9,210 |
|
|
|
6,079 |
|
|
|
16,642 |
|
|
|
11,896 |
|
Amortization |
|
|
29,016 |
|
|
|
4,208 |
|
|
|
59,755 |
|
|
|
8,335 |
|
Marketing and promotion |
|
|
7,120 |
|
|
|
4,252 |
|
|
|
12,585 |
|
|
|
9,177 |
|
Research and development |
|
|
515 |
|
|
|
225 |
|
|
|
1,300 |
|
|
|
345 |
|
Transaction costs |
|
|
8,120 |
|
|
|
18,206 |
|
|
|
33,699 |
|
|
|
20,664 |
|
Total operating expenses |
|
|
87,450 |
|
|
|
61,243 |
|
|
|
206,937 |
|
|
|
104,662 |
|
Operating loss |
|
|
(54,684 |
) |
|
|
(25,960 |
) |
|
|
(123,216 |
) |
|
|
(34,434 |
) |
Interest expense, net |
|
|
(9,940 |
) |
|
|
(4,832 |
) |
|
|
(20,110 |
) |
|
|
(10,568 |
) |
Non-operating income (expense), net |
|
|
64,750 |
|
|
|
(72,649 |
) |
|
|
113,610 |
|
|
|
(86,008 |
) |
Income (loss) before income taxes |
|
|
126 |
|
|
|
(103,441 |
) |
|
|
(29,716 |
) |
|
|
(131,010 |
) |
Income taxes (recovery) |
|
|
(5,671 |
) |
|
|
(14,192 |
) |
|
|
(909 |
) |
|
|
(20,017 |
) |
Net income (loss) |
|
$ |
5,797 |
|
|
$ |
(89,249 |
) |
|
$ |
(28,807 |
) |
|
$ |
(110,993 |
) |
Total net income (loss) attributable to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders of Tilray Inc. |
|
|
(201 |
) |
|
|
(99,900 |
) |
|
|
(41,850 |
) |
|
|
(134,243 |
) |
Non-controlling interests |
|
|
5,998 |
|
|
|
10,651 |
|
|
|
13,043 |
|
|
|
23,250 |
|
Other comprehensive (loss) income, net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation (loss) gain |
|
|
(32,367 |
) |
|
|
(910 |
) |
|
|
(133,139 |
) |
|
|
475 |
|
Unrealized loss on convertible notes receivable |
|
|
52 |
|
|
|
— |
|
|
|
(597 |
) |
|
|
— |
|
Change in fair value of long-term investments |
|
|
(16,357 |
) |
|
|
— |
|
|
|
(16,357 |
) |
|
|
— |
|
Total other comprehensive (loss) income, net of tax |
|
|
(48,672 |
) |
|
|
(910 |
) |
|
|
(150,093 |
) |
|
|
475 |
|
Comprehensive loss |
|
|
(42,875 |
) |
|
|
(90,159 |
) |
|
|
(178,900 |
) |
|
|
(110,518 |
) |
Total comprehensive income (loss) attributable to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders of Tilray Inc. |
|
|
(41,853 |
) |
|
|
(100,810 |
) |
|
|
(184,923 |
) |
|
|
(133,768 |
) |
Non-controlling interests |
|
|
(1,022 |
) |
|
|
10,651 |
|
|
|
6,023 |
|
|
|
23,250 |
|
Weighted average number of common shares - basic |
|
|
460,254,275 |
|
|
|
243,477,655 |
|
|
|
454,797,598 |
|
|
|
242,207,388 |
|
Weighted average number of common shares - diluted |
|
|
460,254,275 |
|
|
|
243,477,655 |
|
|
|
454,797,598 |
|
|
|
242,207,388 |
|
Net income (loss) per share - basic |
|
$ |
(0.00 |
) |
|
$ |
(0.41 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.55 |
) |
Net income (loss) per share - diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.41 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.55 |
) |
The accompanying notes are an integral part of these consolidated financial statements.
2
TILRAY, INC.
Consolidated Statements of Stockholders’ Equity
(in thousands of United States dollars, except for share data, unaudited)
|
|
Number of
common
shares |
|
|
Common
stock |
|
|
Additional
paid-in
capital |
|
|
Accumulated
other
comprehensive
income (loss) |
|
|
Accumulated Deficit |
|
|
Non-
controlling
interests |
|
|
Total |
|
Balance at May 31, 2020 |
|
|
240,132,635 |
|
|
$ |
24 |
|
|
$ |
1,366,736 |
|
|
$ |
(5,434 |
) |
|
$ |
(113,352 |
) |
|
$ |
26,957 |
|
|
$ |
1,274,931 |
|
Share issuance - legal settlement |
|
|
1,389,884 |
|
|
|
— |
|
|
|
7,018 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
7,018 |
|
Share issuance - options exercised |
|
|
41,065 |
|
|
|
— |
|
|
|
4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
Share issuance - RSUs exercised |
|
|
429,280 |
|
|
|
— |
|
|
|
2,246 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,246 |
|
Share-based payments |
|
|
— |
|
|
|
— |
|
|
|
1,233 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,233 |
|
Comprehensive income (loss) for the period |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,385 |
|
|
|
(34,343 |
) |
|
|
12,599 |
|
|
|
(20,359 |
) |
Balance at August 31, 2020 |
|
|
241,992,864 |
|
|
$ |
24 |
|
|
$ |
1,377,237 |
|
|
$ |
(4,049 |
) |
|
$ |
(147,695 |
) |
|
$ |
39,556 |
|
|
$ |
1,265,073 |
|
Share issuance - legal settlement |
|
|
503,974 |
|
|
|
— |
|
|
|
3,436 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,436 |
|
Share issuance - equity financing |
|
|
14,610,496 |
|
|
|
2 |
|
|
|
103,594 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
103,596 |
|
Share issuance - SweetWater acquisition |
|
|
8,232,810 |
|
|
|
1 |
|
|
|
69,189 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
69,190 |
|
Share issuance - options exercised |
|
|
74,337 |
|
|
|
— |
|
|
|
86 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
86 |
|
Share issuance - RSUs exercised |
|
|
8,823 |
|
|
|
— |
|
|
|
306 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
306 |
|
Share-based payments |
|
|
— |
|
|
|
— |
|
|
|
1,017 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,017 |
|
Comprehensive income (loss) for the period |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(910 |
) |
|
|
(99,900 |
) |
|
|
10,651 |
|
|
|
(90,159 |
) |
Balance at November 30, 2020 |
|
|
265,423,304 |
|
|
$ |
27 |
|
|
$ |
1,554,865 |
|
|
$ |
(4,959 |
) |
|
$ |
(247,595 |
) |
|
$ |
50,207 |
|
|
$ |
1,352,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|